1. Home
  2. CYTK vs MICC Comparison

CYTK vs MICC Comparison

Compare CYTK & MICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

SELL

Current Price

$54.70

Market Cap

10.7B

Sector

Health Care

ML Signal

SELL

MICC

The Magnum Ice Cream Company N.V. Ordinary Shares

HOLD

Current Price

$20.07

Market Cap

12.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
MICC
Founded
1997
2025
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.2B
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
CYTK
MICC
Price
$54.70
$20.07
Analyst Decision
Buy
Hold
Analyst Count
22
4
Target Price
★ $107.39
$19.58
AVG Volume (30 Days)
★ 1.6M
833.0K
Earning Date
11-04-2026
02-12-2027
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $13,368,000.00
N/A
Revenue This Year
$79.67
$6.51
Revenue Next Year
$172.23
$4.35
P/E Ratio
★ N/A
$28.55
Revenue Growth
N/A
★ N/A
52 Week Low
$58.25
$12.94
52 Week High
$88.31
$20.69

Technical Indicators

Market Signals
Indicator
CYTK
MICC
Relative Strength Index (RSI) 52.28 60.86
Support Level $63.96 $18.83
Resistance Level $66.93 $20.69
Average True Range (ATR) 2.04 0.35
MACD 0.50 0.15
Stochastic Oscillator 86.71 91.69

Price Performance

Historical Comparison
CYTK
MICC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About MICC The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Co., spun off from Unilever, manufactures and sells a broad portfolio of ice cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice cream brands: Heartbrand (an umbrella brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.

Share on Social Networks: